Frequency Therapeutics, Inc. (FREQ)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
24,018
36,984
28,947
0
0
Operating Expenses
Research Development
58,563
36,656
18,784
11,880
11,966
Selling General and Administrative
36,970
27,119
30,838
7,064
4,340
Total Operating Expenses
96,967
64,534
49,622
18,944
16,306
Operating Income or Loss
-72,949
-27,550
-20,675
-18,944
-16,306
Interest Expense
-
-
-
106
174
Total Other Income/Expenses Net
-246
80
145
-118
-3,757
Income Before Tax
-73,430
-26,476
-18,746
-19,168
-20,237
Income Tax Expense
-12
35
-
-
-
Income from Continuing Operations
-73,418
-26,511
-18,746
-19,168
-20,237
Net Income
-73,418
-26,511
-18,746
-19,168
-20,237
Net Income available to common shareholders
-73,418
-26,511
-19,800
-19,168
-20,237
Basic EPS
-
-0.82
-2.29
-1.59
-1.12
Diluted EPS
-
-0.82
-2.29
-1.59
-1.12
Basic Average Shares
-
32,253
8,649
12,061
18,116
Diluted Average Shares
-
32,253
8,649
12,061
18,116
EBITDA
-
-26,404
-19,862
-18,408
-15,775
